Indian drug maker Dr. Reddy's Laboratories will release a generic of molnupiravir, a tablet from Merck's COVID-19. The drug will be sold under the brand name Molflu. The total cost of a 5-day course of treatment, consisting of 40 capsules, will be ₹1,400, or $18.77, while the original Merck pills cost $700. Molflu sales across India are scheduled to begin next week.
Indian drug maker Dr. Reddy's Laboratories will release a generic of molnupiravir, a tablet from Merck's COVID-19. The drug will be sold under the brand name Molflu. The total cost of a 5-day course of treatment, consisting of 40 capsules, will be ₹1,400, or $18.77, while the original Merck pills cost $700. Molflu sales across India are scheduled to begin next week. 
reuters.com
English (US) 